T L Ortel - JoVE Visualize

Showing results (41-50 of 69) with videos related to

Pageof 7

Sort By:

The Journal of Clinical Investigation|December 1, 1992

Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activityT L Ortel, M A Quinn-Allen, L A Charles, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 8, 2002

Abnormal optical waveform profiles in coagulation assays from patients with antiphospholipid antibodiesZ Su, P J Braun, K F Klemp, et al.

Seminars in Hematology|December 6, 2001

Tissue factor in experimental acute lung injuryK E Welty-Wolf, M S Carraway, S Idell, et al.

Blood|August 15, 1993

Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuriaT Wiedmer, S E Hall, T L Ortel, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 1, 1983

Internal triplication in the structure of human ceruloplasminN Takahashi, R A Bauman, T L Ortel, et al.

The Journal of Biological Chemistry|June 3, 1994

Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimerasT L Ortel, M A Quinn-Allen, F G Keller, et al.

Radiology|August 1, 1994

Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findingsJ M Provenzale, E R Heinz, T L Ortel, et al.

Journal of Thrombosis and Haemostasis : JTH|July 24, 2009

Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and HaemostasisV Pengo, A Tripodi, G Reber, et al.

Clinical Chemistry|October 1, 1994

Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2C S Greenberg, M J Hursting, B G Macik, et al.

Thrombosis and Haemostasis|March 2, 1992

Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosisT L Ortel, J P Gockerman, R M Califf, et al.

Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:

Pageof 7

The Journal of Clinical Investigation|December 1, 1992

Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activityT L Ortel, M A Quinn-Allen, L A Charles, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 8, 2002

Abnormal optical waveform profiles in coagulation assays from patients with antiphospholipid antibodiesZ Su, P J Braun, K F Klemp, et al.

Seminars in Hematology|December 6, 2001

Tissue factor in experimental acute lung injuryK E Welty-Wolf, M S Carraway, S Idell, et al.

Blood|August 15, 1993

Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuriaT Wiedmer, S E Hall, T L Ortel, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 1, 1983

Internal triplication in the structure of human ceruloplasminN Takahashi, R A Bauman, T L Ortel, et al.

The Journal of Biological Chemistry|June 3, 1994

Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimerasT L Ortel, M A Quinn-Allen, F G Keller, et al.

Radiology|August 1, 1994

Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findingsJ M Provenzale, E R Heinz, T L Ortel, et al.

Journal of Thrombosis and Haemostasis : JTH|July 24, 2009

Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and HaemostasisV Pengo, A Tripodi, G Reber, et al.

Clinical Chemistry|October 1, 1994

Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2C S Greenberg, M J Hursting, B G Macik, et al.

Thrombosis and Haemostasis|March 2, 1992

Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosisT L Ortel, J P Gockerman, R M Califf, et al.

Pageof 7